🧠 Calquify Intelligence
Germany's DAX delivered +18.9% in 2024 despite Germany being in technical recession for the second consecutive year — the apparent contradiction is explained by the DAX's multinational composition (German-listed companies deriving approximately 70% of revenues outside Germany) and the defence/industrial re-armament theme that drove SAP, Rheinmetall, and Siemens to record highs
DAX top performers 2024: SAP (Europe's largest software company): +60%; Rheinmetall (defence): +50% (NATO re-armament spending wave); Deutsche Telekom: +30%; Siemens: +25%; Munich Re: +20%. German GDP growth 2024: approximately -0.1% (technical recession, second year). The paradox: Germany's largest companies are global multinationals — SAP derives approximately 80% of revenues from outside Germany; BMW and Mercedes export majority of cars to Asia/US; BASF has major US and Asian production. The DAX is not a gauge of the German economy — it's a portfolio of multinationals that happen to be listed in Frankfurt. DAX's exposure to defence (Rheinmetall, Hensoldt, Diehl) benefited from European NATO 2% GDP commitment following Russia-Ukraine war. Rheinmetall's 155mm artillery shell production tripling drove the stock from €80 (2021) to €500+ (2025) — one of European equity's most dramatic sector themes.
Source: Deutsche Börse DAX constituent returns 2024; Bloomberg; Rheinmetall AR 2024; SAP annual results
France's CAC 40 was Europe's worst-performing major index in 2024 at -2.2% — driven by political risk from Macron's snap election, luxury sector correction (LVMH -12%, Kering -37%), and the OAT-Bund spread widening that penalised French financial stocks — illustrating how political uncertainty can overwhelm company fundamentals
CAC 40 return breakdown 2024: LVMH -12% (Chinese luxury demand slowdown; lower US travel retail; Hong Kong tourist decline); Kering -37% (Gucci brand crisis; CEO departure; Chinese wholesale channel problems); Airbus -12% (supply chain delays; engine shortage from CFM LEAP); BNP Paribas -8% (OAT spread widening; higher funding costs; sovereign risk repricing). Positive: TotalEnergies +8%; Sanofi +25%; Safran +35% (defence/aerospace). The snap election (June 2024): markets priced far-left or far-right government risk into French asset prices — both foreign and domestic institutional investors reduced French equity exposure. CAC 40's heavy luxury weighting (LVMH approximately 12% of index; Hermès approximately 8%) meant that the Chinese luxury slowdown disproportionately hurt France versus Germany (industrial) or Spain (financial/utility). The combination of political risk + China luxury exposure + fiscal concerns made France the outlier in an otherwise positive European year.
Source: Euronext Paris CAC 40 returns 2024; Bloomberg; LVMH annual results; Kering Q4 2024; OAT spread data
European stock markets have structurally underperformed US markets over the last decade — STOXX 600 10yr annualised total return approximately 7-8% versus S&P 500 approximately 13% — but this gap is partly explained by sector composition rather than European corporate inferiority, and European valuations (P/E approximately 13-15×) offer more value versus US (P/E approximately 20-22×) entering 2026
10-year annualised total returns (in EUR/GBP): STOXX Europe 600 approximately 7.5%; S&P 500 approximately 12.5% (in EUR terms, accounting for USD appreciation). Gap: approximately 500bp/year over a decade. Sector explanation: US technology (approximately 30% of S&P 500 weight) grew at 20-25%/year in the 2010s — AI bubble, cloud computing, mobile internet; European index has minimal pure-play technology exposure (approximately 7-8% of STOXX 600). Without technology, the gap narrows substantially — European financials, industrials, and consumer staples have broadly matched US equivalents in their respective sectors. Valuation entry point: STOXX 600 forward P/E approximately 13-14× (Q3 2025) versus S&P 500 approximately 21-22×. The valuation gap is the largest in 20 years — implying either European markets are genuinely undervalued or US earnings growth justifies the premium. Most major asset allocators (BlackRock, Goldman Sachs) have published overweight Europe recommendations for 2025-2026 specifically due to this valuation differential.
Source: STOXX index return series 2014-2025; MSCI ACWI Europe vs US; Goldman Sachs European equity strategy 2025; FactSet earnings valuation
2024 Total Return by European Index (%)
Bloomberg + STOXX 2024
📋 Reference Data
European Stock Market Index Returns — 2024 and Annualised Multi-Year
Bloomberg + STOXX total return data
| Index | Country | 2024 Return | 2023 Return | 5yr CAGR | 10yr CAGR | Dividend Yield | Currency | Notes |
|---|---|---|---|---|---|---|---|---|
| DAX | Germany | +18,9% | +19,3% | ~+9,5% | ~+8,2% | ~2,6% | EUR | Total return index; tech/defence 2024 drivers |
| IBEX 35 | Spain | +14,8% | +23,0% | ~+7,5% | ~+4,8% | ~4,5% | EUR | Banks+utilities; best yield index; consistent |
| AEX | Netherlands | +13,4% | +17,1% | ~+10,5% | ~+9,8% | ~2,8% | EUR | ASML dominant; tech-heavy; outperformer |
| EURO STOXX 50 | Eurozone | +10,1% | +22,3% | ~+8,5% | ~+6,8% | ~3,3% | EUR | Core 50 Eurozone; liquid benchmark |
| STOXX Europe 600 | Pan-Europe | +8,0% | +16,6% | ~+8,0% | ~+7,5% | ~3,4% | EUR | Broad benchmark; 600 stocks; diversified |
| OMX Stockholm 30 | Sweden | +7,5% | +18,5% | ~+8,0% | ~+8,2% | ~3,0% | SEK | Investor AB, Ericsson, Atlas Copco; SEK terms |
| SMI | Switzerland | +4,0% | +3,8% | ~+6,0% | ~+7,5% | ~3,1% | CHF | Defensive; Nestlé+Novartis+Roche ~50% weight |
| OMX Copenhagen | Denmark | +5,2% | -17,4% | ~+12,0% | ~+14,5% | ~3,2% | DKK | Novo Nordisk dominant; pharma growth; volatile |
| FTSE 100 | UK | +5,7% | +7,9% | ~+6,5% | ~+6,0% | ~3,8% | GBP | Energy/mining heavy; GBP dilation; value |
| CAC 40 | France | -2,2% | +16,5% | ~+7,8% | ~+7,1% | ~3,5% | EUR | Political disruption 2024; luxury correction |
| BEL 20 | Belgium | -1,5% | +10,2% | ~+6,5% | ~+7,0% | ~3,7% | EUR | AB InBev heavy; modest 2024; consistent income |
| ATX | Austria | +0,8% | +9,5% | ~+6,0% | ~+5,5% | ~4,2% | EUR | Bank-heavy; CEE exposure; low valuation |
| WIG 20 | Poland | +7,8% | +26,0% | ~+6,5% | ~+2,5% | ~3,5% | PLN | Warsaw; CEE largest; banking driven; PLN |
| MIB (FTSE Italia) | Italy | +12,5% | +28,0% | ~+8,5% | ~+4,5% | ~4,5% | EUR | UniCredit surge; banks dominant; BTP correlation |
ⓘ All returns are total return (dividends reinvested) in local currency. EUR-based investors in UK FTSE 100 also experienced GBP/EUR exchange rate impact (GBP strengthened approximately +2% vs EUR in 2024 — small positive for EUR investors). 5yr and 10yr CAGR are estimated compound annual growth rates. Denmark OMX Copenhagen's 10yr CAGR of approximately +14.5% reflects Novo Nordisk's extraordinary run (+700% in 7 years) — without Novo, Denmark's return is far more ordinary (approximately 7-8%). FTSE MIB (Italy) +28% in 2023 was driven by UniCredit's dramatic profitability recovery — Italian bank stocks recovered from near-zero yields to 7%+ as ECB rates enabled the best bank margins in decades.
European vs US Stock Market — 10yr Comparative Performance
MSCI + Bloomberg total return in EUR Q1 2015 – Q3 2025
| Market | 10yr CAGR (EUR) | 2024 Return (EUR) | Forward P/E | Dividend Yield | Key Characteristic | Outlook Consensus |
|---|---|---|---|---|---|---|
| US S&P 500 | ~+12,5% EUR | ~+22% EUR | ~21–22× | ~1,4% | Technology dominant (30%); AI theme | Many analysts caution on valuation |
| STOXX Europe 600 | ~+7,5% EUR | ~+8,0% | ~13–14× | ~3,4% | Financial/industrial; value-oriented | Overweight recommendations increasing |
| UK FTSE 100 | ~+6,0% EUR | ~+5,7% GBP | ~11–12× | ~3,8% | Energy/mining/banks; deep value | Structural undervaluation; income focus |
| Japan TOPIX (JPY→EUR) | ~+8,0% EUR | ~+15% EUR | ~14–15× | ~2,2% | Corporate governance reform; cheap | Governance uplift story; FX risk |
| Emerging Markets MSCI | ~+3,5% EUR | ~+5% EUR | ~12–13× | ~3,0% | China-heavy (30%); high variance | High variance; China uncertainty |
| Denmark OMX | ~+14,5% EUR | ~+5,2% | ~24× (Novo) | ~3,2% | Novo Nordisk concentration risk | Novo-dependent; pharma slowdown risk |
ⓘ EUR-equivalent returns show what a Eurozone investor actually received after currency conversion. US S&P 500's 10yr CAGR of approximately +12.5% in EUR terms reflects both US equity outperformance AND USD appreciation versus EUR over the decade. The European valuation case (P/E 13-14× versus US 21-22×) is the most compelling valuation argument for European equities since 2010 — but cheap has often stayed cheaper for longer than fundamental analysts expect. The consensus overweight European equity view for 2025-2026 is shared by Goldman Sachs, JPMorgan, and BlackRock — driven by ECB rate cuts, European defence spending re-armament, and the extreme valuation gap.
🔗 Explore Related Intelligence
→
Investment & Finance
Dividend Yields Europe 2026
Equity income
→
Investment & Finance
Bond Yields Europe 2026
Sovereign bond yields
→
Investment & Finance
ETF Total Expense Ratios Europe 2026
ETF costs
→
Investment & Finance
Savings Rates Europe 2026
Best savings rates
🔬 Methodology & Sources
Stock Market Total Returns
Total return indices include dividend reinvestment — the most meaningful measure for investors. Price-only (price return) indices exclude dividends. DAX is already a total return index (dividends reinvested). FTSE 100, CAC 40, STOXX 600 have separate TR versions. Returns shown are local currency — EUR-based investors in UK stocks also experience GBP/EUR FX impact. 10-year annualised returns represent CAGR (compound annual growth rate).
Formula
Total_return = (end_value + dividends_reinvested) / start_value - 1 | CAGR = (end_value / start_value)^(1/years) - 1 | Sharpe = (return - risk_free) / volatility
CitationSTOXX index statistics; Bloomberg; MSCI ACWI Europe returns; Morningstar pan-European returns data.
❓ Frequently Asked Questions
In 2024, Germany's DAX was the best-performing major European index at +18.9%, driven by SAP (+60%), Rheinmetall (+50% on defence spending), and Deutsche Telekom (+30%). IBEX 35 (Spain) returned +14.8% driven by banks and utilities. AEX (Netherlands) +13.4% on ASML's AI-linked semiconductor equipment demand. The worst performer was France's CAC 40 at -2.2%, hit by political disruption from Macron's snap election and a luxury sector correction (LVMH -12%, Kering -37%).
European stocks (STOXX 600) have significantly underperformed US stocks (S&P 500) over the past decade — approximately +7.5% CAGR versus +12.5% CAGR in EUR terms. The gap is largely explained by sector composition: the S&P 500 is approximately 30% technology (which grew 20-25%/year in the 2010s); the STOXX 600 has approximately 7-8% technology. Valuations have diverged substantially as a result: STOXX 600 forward P/E approximately 13-14× versus S&P 500 approximately 21-22×. Many analysts now argue European equities are attractively valued relative to US alternatives — entering 2026, overweight Europe is a consensus institutional view for the first time in years.
The DAX (Deutsches Aktienindex) is Germany's primary stock market index, consisting of the 40 largest German companies listed on the Frankfurt Stock Exchange (formerly 30 companies until 2021 expansion). Key distinction: the DAX is a total return index — dividends are automatically reinvested in the calculation, unlike FTSE 100 or CAC 40 which are traditionally quoted as price-only (separate total return versions exist). This makes DAX returns appear higher than price-only European equivalents. For fair comparison: always use total return versions of all indices. The DAX's 40 constituents are dominated by globally-focused multinationals: SAP (technology), Siemens (industrial), Allianz (insurance), BASF (chemicals), BMW/Mercedes-Benz/Volkswagen (automotive), Deutsche Telekom, Bayer (pharma), Rheinmetall (defence).
Denmark's OMX Copenhagen generated approximately +14.5% CAGR over 10 years — the best of any major European index — almost entirely due to Novo Nordisk's extraordinary run. Novo Nordisk (manufacturer of Ozempic/Wegovy GLP-1 diabetes and obesity drugs) grew from approximately DKK 100 (2015) to DKK 700+ (2024 peak), adding approximately $500bn in market capitalisation. Novo Nordisk reached a peak weight of approximately 60% of the entire OMX Copenhagen index — making Denmark's national stock index essentially a leveraged bet on GLP-1 drugs. In 2024, Novo declined approximately 20-25% from its peak as competition concerns (Eli Lilly's tirzepatide), supply constraints, and valuation reversion emerged — causing the Danish index to significantly underperform despite strength in other constituents like Maersk and Vestas.
This is a personal investment decision that depends on your risk tolerance, time horizon, existing portfolio, and tax situation — Claude cannot make investment recommendations. What the data shows: European stocks (STOXX 600: P/E approximately 13-14×, yield approximately 3.4%) appear significantly cheaper than US stocks (S&P 500: P/E approximately 21-22×, yield approximately 1.4%). Historical European underperformance versus US is mainly explained by sector composition differences (less technology). ECB rate cuts and European defence spending are positive catalysts for 2025-2026. Many institutional investors overweight Europe for the first time in years. Speak to a regulated financial advisor (UK: FCA-authorised IFA; EU: MiFID II registered) for personalised investment advice.
Sources & References
Data sourced from official institutional publications. Results are for informational purposes only. Last reviewed Jan 2026.
Data Disclaimer
Past stock market returns do not predict future performance. Total returns include dividend reinvestment. Returns shown in local currency unless stated. Equity investment involves risk of capital loss.
Past stock market returns do not predict future performance. Total returns include dividend reinvestment. Returns shown in local currency unless stated. Equity investment involves risk of capital loss.